Bienvenue dans – Welkom bij:
Bienvenidos en – Welcome to:
SFB-Pharma
If you want to reach me please send a message to:
Christine Laroche [email protected]
DRUGS.COM – NEW APPROVALS BELOW
- FDA Approves Qsymia for Chronic Weight Management in Certain Pediatric Patients Aged 12 years and Older
- U.S. FDA Approves Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy
- Novartis Tafinlar + Mekinist Receives FDA Approval for First Tumor-Agnostic Indication for BRAF V600E Solid Tumors
- U.S. FDA Approves Merck’s Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Infants and Children
- Skyrizi (risankizumab-rzaa) Receives FDA Approval as the First and Only Specific Interleukin-23 (IL-23) to Treat Moderately to Severely Active Crohn's Disease in Adults